1. Home
  2. ELTX vs PETS Comparison

ELTX vs PETS Comparison

Compare ELTX & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

N/A

Current Price

$1.52

Market Cap

45.6M

Sector

Health Care

ML Signal

N/A

Logo PetMed Express Inc.

PETS

PetMed Express Inc.

N/A

Current Price

$0.94

Market Cap

23.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
ELTX
PETS
Founded
2011
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Drug Stores and Proprietary Stores
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
45.6M
23.7M
IPO Year
2014
2003

Fundamental Metrics

Financial Performance
Metric
ELTX
PETS
Price
$1.52
$0.94
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $13.00
N/A
AVG Volume (30 Days)
★ 305.0K
107.4K
Earning Date
11-05-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 39.29
N/A
EPS
N/A
★ N/A
Revenue
$2,301,000.00
★ $273,800,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.24
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.25
$0.93
52 Week High
$16.00
$4.10

Technical Indicators

Market Signals
Indicator
ELTX
PETS
Relative Strength Index (RSI) 40.97 22.10
Support Level $1.35 N/A
Resistance Level $1.98 $1.27
Average True Range (ATR) 0.19 0.06
MACD 0.01 -0.01
Stochastic Oscillator 42.19 2.96

Price Performance

Historical Comparison
ELTX
PETS

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About PETS PetMed Express Inc.

PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.

Share on Social Networks: